Semler Scientific, Inc. (NASDAQ:SMLR), based in Campbell, California, is renowned for its QuantaFlo vascular testing system. In a bold move, the company has recently pivoted towards Bitcoin investments, significantly impacting its financial performance. Despite facing challenges in its core healthcare operations, Semler's strategic shift into Bitcoin has led to substantial financial gains.
On August 4, 2025, Semler reported an impressive earnings per share (EPS) of $5.04, far exceeding the anticipated loss of $0.27 per share. This remarkable performance is largely attributed to $83.8 million in unrealized gains from its Bitcoin holdings. The company's decision to adopt Bitcoin as its primary treasury reserve asset has proven beneficial, with a 31.3% yield year-to-date through July 31, 2025.
Despite the positive EPS, Semler's core healthcare operations are under pressure, with revenue falling to $8.2 million, below the estimated $8.4 million. This decline underscores the challenges faced by the company's traditional business model. However, the strategic shift towards Bitcoin has provided a financial cushion, enabling Semler to navigate these challenges effectively.
Semler's financial metrics reflect its current situation. The price-to-sales ratio stands at 16.66, showing investor willingness to pay a premium for each dollar of sales. The enterprise value to sales ratio is 18.42, reflecting the company's valuation relative to its sales.
The company's debt-to-equity ratio is 0.59, indicating a moderate level of debt compared to equity. However, the current ratio of 0.52 suggests potential liquidity challenges in meeting short-term obligations. Despite these challenges, Semler's strategic focus on Bitcoin has positioned it as a leading corporate holder, with holdings valued at nearly $586.2 million as of July 31, 2025.
